财经快讯|翰宇药业：利拉鲁肽制剂及多种GLP-1原料药签约订单金额合计近6亿元
翰宇药业5月2日在互动平台表示，截至今日，公司利拉鲁肽制剂及多种GLP-1原料药签约订单金额合计近6亿元，部分订单已陆续出货中；制剂生产基地获得欧盟GMP认证和美国cGMP认证，原料药生产基地通过了澳大利亚TGA-GMP认证和美国cGMP认证。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Novo Nordisk raises outlook fuelled by obesity drug demand By Reuters
Goldman Sachs still sees two rate cuts this year after Powell speech By
Related News
